ECJ BACKS INEOS OVER TRADEMARKING OF ITS ‘ALPHAREN’ BRAND
February 2nd, 2011
BY KEITH NUTHALL
THE EUROPEAN Court of Justice's general court has overturned a ban on Britain's Ineos Healthcare Ltd from using its trademark ALPHAREN to sell certain medicines in Hungary, Latvia and Lithuania. This dispute centres on Ineos medicines containing magnesium iron hydroxy carbonate or hydrotalcite or derivatives; used in renal dialysis and treating renal diseases and kidney ailments; and phosphate binders for treating hyperphosphataemia. Israel's Teva Pharmaceutical Industries had originally persuaded European Union trademark regulator OHIM there ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.